B16F10-hFAP

Export PDF

Strain Information

Cell Line

B16F10-Tg(hFAP)/Smoc

Cat. NO.

NM-S31A-TM03

Model Description

These transgenic cells carry humanized FAP.

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Figure 1. hFAP expression in wild-type B16F10 and B16F10-hFAP cell lines.

image.png

Figure 2. Tumor growth curve of B16F10-hFAP syngeneic model (n=5).

image.png


Figure 3. Body weight change of B16F10-hFAP syngeneic model (n=5).

image.png


Figure 4. The expression of hFAP in humanized modified tumors by FACS.

Related Strain(s)

4T1-hFAP-Luc
Cell Line：

4T1-Tg(hFAP-Luc)Smoc

Cat. NO.：NMC-230017
CT26-hFAP
Cell Line：

CT26-Tg(hFAP)Smoc

Cat. NO.：NMC-230018
NIH/3T3-hFAP
Cell Line：NIH/3T3-Fapem(hFAP)Smoc
Cat. NO.：NM-S08-TM01
L929-hFAP
Cell Line：L929-Fapem(hFAP)Smoc
Cat. NO.：NM-S39A-TM01
WHEI 164-hFAP
Cell Line：

WHEI 164-Fapem(hFAP)Smoc

Cat. NO.：NM-S25A-TM01

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more